Kestra Medical Technologies (KMTS) plans sale of 5,887 vested shares

Rhea-AI Filing Summary

Kestra Medical Technologies, Ltd. filed to permit the sale of up to 5,887 shares of common stock through Merrill Lynch on or about July 30, 2026 on NASDAQ. These shares relate to the vesting of performance share unit awards on July 17, 2026, originally granted as part of issuer equity compensation.

Key Figures

Shares to be sold: 5,887 shares Aggregate market value: $133,892.22 Planned sale date: 07/30/2026 +1 more

4 metrics

Shares to be sold 5,887 shares Common stock proposed for sale through Merrill Lynch

Aggregate market value $133,892.22 Estimated value of the 5,887 shares covered by the notice

Planned sale date 07/30/2026 Date associated with the proposed NASDAQ sale

Vesting date 07/17/2026 Vesting of performance share unit awards that generated the shares

Key Terms

performance share unit awards, equity compensation, Common Stock

3 terms

performance share unit awards financial

"Vesting of performance share unit awards"

equity compensation financial

"Granted as part of issuer equity compensation"

Equity compensation is pay given to employees, executives or contractors in the form of company ownership—such as stock, stock options or restricted shares—rather than just cash. It matters to investors because it can align workers' incentives with shareholders (like paying someone in slices of the same pie they help grow), but it also increases the number of shares outstanding and company expenses, affecting ownership percentages and earnings per share.

Common Stock financial

"Common Stock | Merrill Lynch 225 Liberty Street"

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 07/30/2026 - 04:37 PM Accepted by SEC EDGAR 07/30/2026 - 04:36 PM Learn about SEC filing dates

FAQ

What stock sale is Kestra Medical Technologies (KMTS) registering?

Kestra Medical Technologies is registering a proposed sale of 5,887 shares of its common stock. The shares may be sold through Merrill Lynch on NASDAQ around July 30, 2026 under this notice.

What is the approximate value of the Kestra Medical (KMTS) shares to be sold?

The filing lists an aggregate market value of approximately $133,892.22 for the 5,887 common shares covered. This reflects the estimated value related to the proposed sale described in the notice.

Why are the Kestra Medical (KMTS) shares in this Form 144 being sold?

The 5,887 shares arise from the vesting of performance share unit awards on July 17, 2026. These awards were granted as part of issuer equity compensation to the reporting person.

Which broker and market are involved in the Kestra Medical (KMTS) planned sale?

The planned sale of 5,887 Kestra Medical common shares is listed with Merrill Lynch, located at 225 Liberty Street, New York, and identifies NASDAQ as the trading market for the transaction.

Does the Kestra Medical (KMTS) Form 144 show any other sales in the past 3 months?

The section for securities sold during the past 3 months does not list any additional transactions. The notice focuses on the proposed sale of 5,887 shares from recently vested performance awards.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Merrill Lynch 225 Liberty Street Floor 37 New York NY 10281	5887	133892.22	58602497	07/30/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	07/17/2026	Vesting of performance share unit awards	KESTRA MEDICAL TECHNOLOGIES, LTD.			5887	07/17/2026	Granted as part of issuer equity compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)